Posted in | News | Lighting

Nexxus Lighting Announces Follow-On Offering and Underwriter Options

Nexxus Lighting, Inc. (NASDAQ:NEXS) today announced that it has filed a registration statement with the Securities and Exchange Commission relating to a proposed follow-on offering of its common stock.

Nexxus Lighting intends to offer 5,000,000 shares and the underwriters have an option to purchase an additional 750,000 shares of Nexxus Lighting's common stock to cover over-allotments. The Company intends to use the net proceeds to repay indebtedness and for working capital and general corporate purposes.

Canaccord Adams Inc. is the sole book-runner of the proposed offering and Wedbush Securities will serve as co-manager for the transaction.

There can be no assurance as to whether or when any such offering would be commenced or completed or as to the actual size or terms of any such offering. A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

Once available, a preliminary prospectus relating to these securities may be obtained from Canaccord Adams Inc., Attn: Syndicate Department, 99 High Street, 12th Floor, Boston, MA 02110. Email: mailto:[email protected]. Fax: (617) 788-1553.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.